raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:3312

Thalidomide embryopathy

Synonyms: Fetal thalidomide syndrome

Type
Malformation syndrome
Group
Disorder
Inheritance
Not applicable
Age of onset
Antenatal, Neonatal
Status
active

Thalidomide embryopathy is a group of anomalies present in infants as a result of <i>in utero</i> exposure (between 20-36 days after fertilization) to thalidomide, a sedative used in treatment of a range of conditions, including morning sickness, leprosy and multiple myeloma. Thalidomine embryopathy is characterized by phocomelia, amelia, forelimb and hand plate anomalies (absence of humerus and/or forearm, femur and/or lower leg, thumb anomalies). Other anomalies include facial hemangiomas, and damages to ears (anotia, microtia), eyes (microphthalmia, anophthalmos, coloboma, strabismus), internal organs (kidney, heart, and gastrointestinal tract), genitalia, and heart. Infant mortality associated with thalidomide embryopathy is estimated to be as high as 40%. Thalidomide is contraindicated in pregnancy and pregnancy prevention is recommended in women under treatment.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enThalidomide embryopathyFetal thalidomide syndrome
frEmbryopathie à la thalidomideFoetopathie à la thalidomide
deThalidomid-Embryopathie
esEmbriopatía por talidomida
itEmbriopatia da talidomide
nlThalidomide-embryopathieFoetaal thalidomidesyndroom
ptEmbriopatia por talidomida
plEmbriopatia spowodowana talomidemPłodowy zespół talomidowy
csThalidomidová embryopatieFetální thalidomidový syndrom
ukТалідомідна ембріопатіяТалідомідний синдром плода
zh反应停胎儿病胎儿反应停综合征
trTalidomid embriyopatisifetal talidomid sendromu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10Q86.8NTBTattributedvalidated
ICD-11LD2F.0YNTBTindexvalidated
MONDO0018034Evalidated
UMLSC0432365Evalidated
GARD2313Evalidated
MedDRA10071249Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalence1-9 / 1 000 0000.77 / 100 000WorldwideValue and classNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

17 annotations · validated 2016-06-01
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0030680Abnormal cardiovascular system morphology
HP:0002991Abnormal fibula morphology
HP:0009601Aplasia/Hypoplasia of the thumb
HP:0006495Aplasia/Hypoplasia of the ulna
HP:0005613Aplasia/hypoplasia of the femur
HP:0006507Aplasia/hypoplasia of the humerus
HP:0001177Preaxial hand polydactyly
HP:0004059Radial club hand
HP:0004322Short stature
HP:0001171Split hand
HP:0001199Triphalangeal thumb
HP:0009813Upper limb phocomelia
Occasional (29-5%)
HP:0000356Abnormality of the outer ear
HP:0009892Anotia
HP:0002257Chronic rhinitis
HP:0000365Hearing impairment
HP:0000855Insulin resistance
7

Sources for this card